Streetbeat News

Products Services

TCBP

TC Biopharm (TCBP) has dosed five new patients in its ACHIEVE Phase 2b trial, which is a significant step in their clinical development process.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:41 pm

ANGO

AngioDynamics has received CE Mark approval for its Auryon System in Europe, which is a significant regulatory milestone that could enhance its market presence and sales in the European region.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:37 pm

RKLB

Rocket Lab has announced the launch date for its second dedicated mission for Kinéis, set for September 17, 2024. This mission is part of a series of five Electron launches aimed at deploying a global IoT constellation.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:37 pm

INBS

Intelligent Bio Solutions (INBS) reported a 118% year-over-year increase in the estimated number of employees across its customer base, indicating strong growth and potential increased demand for its products and services.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:36 pm

CVX

Chevron has announced enhancements in oil and natural gas recovery at two of its U.S. facilities. This development is likely to improve production efficiency and output, potentially impacting Chevron's financial performance positively.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm

STOK

Stoke Therapeutics will present data on zorevunersen, a potential first disease-modifying treatment for Dravet syndrome, at the European Epilepsy Congress. The data from Phase 1/2a and OLE studies show significant seizure reduction and cognitive improvements.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm

ARCT

Arcturus Therapeutics has received clearance for its Investigational New Drug (IND) application for ARCT-032, a treatment for cystic fibrosis. This development marks a significant step forward in the company's drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:35 pm

ANIX

Anixa Biosciences presented its ovarian cancer CAR-T therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium, highlighting advancements in cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:34 pm

LVO

TOON

Kartoon Studios and LiveOne have announced a partnership to launch three new audio and video channels: Baby Genius, Stan Lee Presents, and Cartoon Hangover. These channels will target different age groups with tailored entertainment content.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 12:34 pm

BTCUSD

QCP Capital highlights a potential bullish trend for Bitcoin in October, with historical data showing positive returns in eight of the last nine years. Despite a recent 6.7% drop in Bitcoin's price, macroeconomic factors like potential interest rate cuts could boost Bitcoin's value.

Portfolio Pulse from Murtuza Merchant

September 03, 2024 | 12:33 pm